Evaluation of the Trajectory of Depression Severity With Ketamine and Esketamine Treatment in a Clinical Setting.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 35544190.
- Also identified by DOI 10.1001/jamapsychiatry.2022.1074 and PMC identifier 9096687.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This comparative analysis examines the trajectory of depression severity among patients treated with intravenous ketamine or intranasal esketamine in a clinical setting.
Medical subject headings
- Depressive Disorder, Treatment-Resistant
- Ketamine